Operating Cash Flow
STERIS Operating Cash Flow increased by 3.6% to $298.20M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 10.4%, from $332.80M to $298.20M. Over 3 years (FY 2022 to FY 2025), Operating Cash Flow shows an upward trend with a 18.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
Detailed definition
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Peer comparison
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $97.43M | $171.34M | $244.31M | $171.73M | $231.75M | $103.82M | $205.58M | $215.80M | $281.13M | $146.10M | $291.24M | $254.81M | $303.70M | $250.80M | $332.80M | $260.79M | $420.00M | $287.80M | $298.20M |
| QoQ Change | — | +75.9% | +42.6% | -29.7% | +34.9% | -55.2% | +98.0% | +5.0% | +30.3% | -48.0% | +99.4% | -12.5% | +19.2% | -17.4% | +32.7% | -21.6% | +61.1% | -31.5% | +3.6% |
| YoY Change | — | — | — | — | +137.9% | -39.4% | -15.9% | +25.7% | +21.3% | +40.7% | +41.7% | +18.1% | +8.0% | +71.7% | +14.3% | +2.3% | +38.3% | +14.8% | -10.4% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is STERIS's operating cash flow?
- STERIS (STE) reported operating cash flow of $298.20M in Q4 2025.
- How has STERIS's operating cash flow changed year-over-year?
- STERIS's operating cash flow decreased by 10.4% year-over-year, from $332.80M to $298.20M.
- What is the long-term trend for STERIS's operating cash flow?
- Over 3 years (2022 to 2025), STERIS's operating cash flow has grown at a 18.8% compound annual growth rate (CAGR), from $684.81M to $1.15B.
- What does operating cash flow mean?
- The amount of cash a company generates from its regular business activities.